Our Technology

Inside the innovation

How the Technology Works

Molecular Behavior Analysis

EMulate studies the vibrational and electromagnetic characteristics of therapeutic molecules to understand their biological influence.

Signal Encoding

These encoded signatures are transmitted into the body through a wearable device.

Wearable Delivery

Encoded signals are delivered through a compact, lightweight, non-invasive wearable device placed near the target treatment area.

Cellular Response

Cells respond to the signal as though the therapeutic molecule were present, activating pathways associated with healing and functional recovery.

A new class of digital therapeutics.

Platform Strength

Non-Invasive

No surgery, no implants, no systemic exposure.

Drug-Free

Signals aim to replicate molecular effects without chemicals.

Low-to-No Toxicity

Designed to reduce or eliminate treatment-related side effects.

Wearable

Comfortable form factor suited for at- home use.

Tunable & Measurable

Signal patterns can be adjusted with precision.

Compatible

Intended to integrate with standard treatment pathways.

Core Indications Under Development

Oncology

Investigating pathways tied to tumor behavior, growth, and therapeutic resistance.

Neurological & Psychiatric Conditions

Exploring signals that may influence neural circuits involved in mood, cognition, and pain.

Chronic Pain & Symptom Management

Pursuing non-pharmacologic strategies for persistent symptom relief.

From Molecule to Patient

What EMulate Therapeutics Does

From molecular behavior to patient care.
EMulate Therapeutics is building a full therapeutic platform that discovers and encodes molecular signatures, delivers those signals through a compact wearable device, designs and runs clinical studies, and collaborates with clinicians and partners to bring indications through development.

Image showing the electromagnetic spectre. From left to right: ultra-long & low powere weve length(ulRFE), radio waves, visible light, x-rays and gamma ultra-short wave length high energy.

Oncology

Targeting pathways involved in tumor growth, survival, and treatment resistance, with the goal of supporting existing standards of care and opening new options where therapies are limited.

Neurological & Psychiatric Conditions

Exploring signals that may modulate brain networks associated with mood, cognition, and pain, with the aim of developing non-pharmacologic interventions.

Chronic Pain & Symptom Management

Investigating approaches for persistent pain and related symptoms that can be integrated into daily life and used alongside existing treatments.

Program Development

Subsidiaries & Development Pipeline

Each subsidiary progresses through defined development stages, supported by EMulate's ulRFE® platform.

Therapeutic Area Activity Confirmed Animal PoC Validated Human Clinical Pivotal Commercial/Revenue

Oncology

Cellsana Therapeutics, Inc.
Phase:
Activity Confirmed Pivotal Trial Ready: DMG & GBM Phase:
Activity Confirmed
Pivotal Trial Ready: DMG & GBM

Pain Relief

Mensana Therapeutics, Inc.
Phase:
Animal PoC Validated

Animal Health

Phase:
Animal PoC Validated

Ag-Bio

Phase:
Animal PoC Validated

Consumer

Hapbee Technologies, Inc.
Phase:
Commercial/Revenue

Why it Matters

The Problem

Traditional therapies often require a trade-off between effectiveness and quality of life. Many patients face:

  • Significant side effects and toxicity
  • Complex dosing schedules and monitoring
  • Limited options when standard treatments are exhausted

The EMulate Approach

EMulate Therapeutics is working toward solutions that aim to:

  • Be non-invasive and designed for use at home
  • Reduce or avoid systemic toxicity
  • Work alongside established standards of care
  • Deliver measured, tunable signals instead of guesswork

How EMulate Works With
Patients, Clinicians, and Partners

For Patients and Families

EMulate's goal is to create therapies that can become part of everyday life, not just hospital visits. The wearable design and non-invasive approach are being developed to support long- term use where clinically appropriate.

For Clinicians

The platform is intended to be protocol driven and data-rich, with the potential for integration into existing treatment pathways and workflows. EMulate works with investigators and clinical centers to refine indications and best practices.

For Partners and Investors

As a platform technology, ulRFE® has potential applications across multiple indications and therapeutic areas. EMulate collaborates with partners who share a commitment to rigorous evidence, patient-centered design, and responsible innovation.

Scientific Foundation

EMulate's ulRFE® technology is built on evidence showing that precisely patterned electromagnetic fields can influence cellular activity, protein behavior, and biological signaling cascades.

The goal is to deliver targeted biological effects—without exposing the body to chemical drugs or radiation.

Clinical Approach

EMulate Therapeutics is working toward solutions that aim to:

  • Observational and interventional clinical studies
  • Safety and feasibility trials across multiple indications
  • Iterative signal optimization and protocol refinement
  • Partnerships with clinical sites and investigators

Why This Technology Matters

Independent and internal studies continue to show how ulRFE® interacts with biological systems in ways that may open new avenues for treatment. Each published paper strengthens the scientific case behind the technology and informs ongoing preclinical and clinical strategies.

View the latest scientific publications